Cleared Traditional

K192370 - MEDRAD Stellant FLEX CT Injection System with Certegra Workstation (FDA 510(k) Clearance)

Dec 2019
Decision
105d
Days
Class 2
Risk

K192370 is an FDA 510(k) clearance for the MEDRAD Stellant FLEX CT Injection System with Certegra Workstation. This device is classified as a Injector And Syringe, Angiographic (Class II - Special Controls, product code DXT).

Submitted by Bayer Medical Care, Inc. (Whippany, US). The FDA issued a Cleared decision on December 13, 2019, 105 days after receiving the submission on August 30, 2019.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 870.1650.

Submission Details

510(k) Number K192370 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 30, 2019
Decision Date December 13, 2019
Days to Decision 105 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code DXT - Injector And Syringe, Angiographic
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1650